Your browser doesn't support javascript.
loading
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Im, Annie; Rashidi, Armin; Wang, Tao; Hemmer, Michael; MacMillan, Margaret L; Pidala, Joseph; Jagasia, Madan; Pavletic, Steven; Majhail, Navneet S; Weisdorf, Daniel; Abdel-Azim, Hisham; Agrawal, Vaibhav; Al-Homsi, A Samer; Aljurf, Mahmoud; Askar, Medhat; Auletta, Jeffery J; Bashey, Asad; Beitinjaneh, Amer; Bhatt, Vijaya Raj; Byrne, Michael; Cahn, Jean-Yves; Cairo, Mitchell; Castillo, Paul; Cerny, Jan; Chhabra, Saurabh; Choe, Hannah; Ciurea, Stefan; Daly, Andrew; Perez, Miguel Angel Diaz; Farhadfar, Nosha; Gadalla, Shahinaz M; Gale, Robert; Ganguly, Siddhartha; Gergis, Usama; Hanna, Rabi; Hematti, Peiman; Herzig, Roger; Hildebrandt, Gerhard C; Lad, Deepesh P; Lee, Catherine; Lehmann, Leslie; Lekakis, Lazaros; Kamble, Rammurti T; Kharfan-Dabaja, Mohamed A; Khandelwal, Pooja; Martino, Rodrigo; Murthy, Hemant S; Nishihori, Taiga; O'Brien, Tracey A; Olsson, Richard F.
Afiliação
  • Im A; University of Pittsburgh/UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.
  • Rashidi A; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Wang T; Department of Medicine, Medical College of Wisconsin, CIBMTR® (Center for International Blood and Marrow Transplant Research), Milwaukee, Wisconsin; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Hemmer M; Department of Medicine, Medical College of Wisconsin, CIBMTR® (Center for International Blood and Marrow Transplant Research), Milwaukee, Wisconsin.
  • MacMillan ML; Blood and Marrow Transplant Program, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • Pidala J; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
  • Jagasia M; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Pavletic S; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.
  • Majhail NS; Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio.
  • Weisdorf D; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Abdel-Azim H; (0)Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California.
  • Agrawal V; Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
  • Al-Homsi AS; (2)New York University Langone Medical Center, New York, New York.
  • Aljurf M; (3)Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Askar M; (4)Department of Pathology and Laboratory Medicine, Baylor University Medical Center, Dallas, Texas.
  • Auletta JJ; (5)Blood and Marrow Transplant Program and Host Defense Program, Divisions of Hematology/Oncology/Bone Marrow Transplant and Infectious Diseases, Nationwide Children's Hospital, Columbus, Ohio.
  • Bashey A; (6)Blood and Marrow Transplant Program at Northside Hospital, Atlanta, Georgia.
  • Beitinjaneh A; (7)Department of Hematology and Oncology, University of Miami, Miami, Florida.
  • Bhatt VR; (8)The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, Nebraska.
  • Byrne M; Vanderbilt University Medical Center, Nashville, Tennessee.
  • Cahn JY; Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
  • Cairo M; (0)Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, New York.
  • Castillo P; (1)UF Health Shands Children's Hospital, Gainesville, Florida.
  • Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts.
  • Chhabra S; Department of Medicine, Medical College of Wisconsin, CIBMTR® (Center for International Blood and Marrow Transplant Research), Milwaukee, Wisconsin.
  • Choe H; (3)James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, Ohio.
  • Ciurea S; (4)The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Daly A; (5)Tom Baker Cancer Center, Calgary, Alberta, Canada.
  • Perez MAD; (6)Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
  • Farhadfar N; (7)Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida.
  • Gadalla SM; (8)Division of Cancer Epidemiology & Genetics, NIH-NCI Clinical Genetics Branch, Rockville, Maryland.
  • Gale R; Hematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, United Kingdom.
  • Ganguly S; (0)Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
  • Gergis U; (1)Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Hanna R; (2)Cleveland Clinic Foundation, Cleveland, Ohio.
  • Hematti P; Division of Hematology/Oncology/Bone Marrow Transplantation, Department of Medicine, University of Wisconsin, Madison, Wisconsin.
  • Herzig R; (4)University of Kentucky Chandler Medical Center, Louisville, Kentucky.
  • Hildebrandt GC; (5)Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
  • Lad DP; (6)Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Lee C; (7)Utah Blood and Marrow Transplant Program at Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
  • Lehmann L; (8)Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts.
  • Lekakis L; (7)Department of Hematology and Oncology, University of Miami, Miami, Florida.
  • Kamble RT; Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
  • Kharfan-Dabaja MA; (0)Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Khandelwal P; (1)Division of Bone Marrow Transplant and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; (2)Department of Pediatrics, University of Cincinnati, Cincinnati, Ohio.
  • Martino R; (3)Divison of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Murthy HS; (0)Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Nishihori T; Department of Blood & Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa, Florida.
  • O'Brien TA; (5)Blood & Marrow Transplant Program, Kids Cancer Centre, Sydney Children's Hospital, Sydney, Australia.
  • Olsson RF; (6)Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; (7)Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden.
Biol Blood Marrow Transplant ; 26(8): 1459-1468, 2020 08.
Article em En | MEDLINE | ID: mdl-32434056
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article